Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

5.620 USD +0.040 (+0.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
First Week of September 17th Options Trading For Agenus (AGEN)
Investors in Agenus Inc (AGEN) saw new options begin trading this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGEN options chain... 
Tags Stocks
From Market News Video
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
From GlobeNewswire News Releases
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
From GlobeNewswire News Releases
How The Pieces Add Up: WDNA Headed For $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
FinancialBuzz.com News Commentary 
From PR Newswire
Agenus to Participate in the Raymond James 2021 Human Health Innovation Conference
From GlobeNewswire News Releases
First Week of February 2022 Options Trading For Agenus (AGEN)
Investors in Agenus Inc (AGEN) saw new options become available this week, for the February 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
50 Biggest Movers From Yesterday
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO ... 
Tags Markets Health Care JFU
From Benzinga
Noteworthy Thursday Option Activity: RGLD, COMM, AGEN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Royal Gold Inc (RGLD), where a total volume of 1,901 contracts has been traded thus... 
Tags Stocks
From Market News Video
Why Agenus Stock Is Marching Higher Today
The biotech took a major step toward becoming a commercial-stage cancer company. 
Tags AGEN Market News BMY
From Motley Fool
34 Stocks Moving In Thursday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration ... 
Tags News TDUP PRTA
From Benzinga
Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer
TheFDA has accepted for reviewAgenus Inc's(NASDAQ: AGEN) marketing application seeking approval for balstilimab ... 
Tags Market News Health Care Benzinga
From Benzinga
Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer
From GlobeNewswire News Releases
Agenus Announces Virtual Annual Shareholders Meeting
From GlobeNewswire News Releases
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ... 
Tags Options VEEV BZI/AUOA
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! Let's keep the positive momentum going with a look at the biggest pre-market stock movers for Wednesday. The post... 
Tags CLNE PATH Today's Market
From InvestorPlace
75 Biggest Movers From Yesterday
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail ... 
Tags Pre/Market Outlook AIH LFMD
From Benzinga
Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Why Agenus Stock Is Jumping Today
There was some positive news, but it probably wasn't a huge catalyst for the stock. 
Tags AGEN Market News VBIV
From Motley Fool
VBI Vaccines Granted FDA Fast Track Designation for VBI-1901 for the Treatment of Recurrent GBM
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the U.S. Food and Drug... 
From Business Wire News Releases
Agenus’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab and Provide Clinical Update on AGEN2373
From GlobeNewswire News Releases
Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference
From GlobeNewswire News Releases
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May ... 
Tags SNSE CTIC NEXI
From Benzinga
Hot Penny Stocks To Buy On Robinhood With Upcoming Events This Week
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
3 Biotech Stocks That Jumped Higher Last Week
Find out what pushed them up to see if the good times can keep rolling. 
Tags HZNP XBI BMY
From Motley Fool
4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60%
The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and... 
Tags Market News Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why 'Killer' T Cells Could Boost COVID Immunity In Face Of New Variants
Financialnewsmedia.com News Commentary 
From PR Newswire
VBI Vaccines to Present Updated Phase 2a Tumor Response and Overall Survival Data for VBI-1901 in Recurrent GBM at 2021 ASCO Annual Meeting
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that expanded tumor response... 
From Business Wire News Releases
Agenus Presents New Data on Balstilimab and AGEN2373 in ASCO Abstracts
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.